Join Health Foundry for an exciting introductory session to productising healthtech!
Posted:
Lunch&Learn: Productising HealthTech
Mon, 19 April 2021, Online
13:30 – 14:30 CEST
Clinical need should be paramount, but without effective productisation, your solution can't be bought or used.
This session unpacks some of the key issues and decisions faced in turning HealthTech solutions into products. Productisation decisions are difficult because they force standardisation and remove customer choice. Counterintuitively, it's this reduction in choice which enables scale delivery.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…